. Author manuscript; available in PMC: 2016 Mar 1.

Published in final edited form as: Dig Liver Dis. 2014 Nov 24;47(3):197–201. doi: 10.1016/j.dld.2014.11.009

Table 4.

Therapeutic data of subjects with eosinophilic gastrointestinal disorders.

Pharmacologic therapy, N (%)
Diet modification	21 (47)
Mast cell inhibitor	2 (4)
H-2 antagonist	18 (40)
Leukotriene receptor antagonist	6 (13)
Greater than 1 therapy	34 (76)
Oral corticosteroids	36 (80)
Systemic steroids	9 (25)
Topical steroids	27 (75)
Repeat endoscopy performed	29 (66)
Response rate, N (%)
Endoscopic resolution	23 (51)
Symptom resolution	27 (61)
Histologic resolution	20 (69)

Repeat endoscopy – esophagogastroduodenoscopy or colonoscopy.

Symptom resolution – 22/36 patients on steroids, 12/21 patients placed on dietary modification, 15/21 patients received both steroids and dietary modification.